Fludeoxyglucose F-18: Side Effects, Uses & Monitoring
Fludeoxyglucose F 18 Injection,USP is indicated in PET (positron emission tomography) for: 1.
- Data source
- FDA labeling via NIH DailyMed (label 784c3855…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
No structured frequency data available in current labeling. Consult the official label.
Labeled uses (from FDA prescribing information)
Fludeoxyglucose F 18 Injection,USP is indicated in PET (positron emission tomography) for: 1. Identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures. 2. Assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. 3. Assessment of patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging, for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function. Fludeoxyglucose F 18 Injection, USP is not indicated for distinguishing epileptogenic foci from brain tumors or other brain lesions which may cause seizures.
Conditions associated with Fludeoxyglucose F-18 in labeling
Frequently Asked Questions
What is Fludeoxyglucose F-18 used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Fludeoxyglucose F-18?
Current labeling for this ingredient does not include a structured frequency table that we can reproduce. Review the official label linked below.
Does Fludeoxyglucose F-18 require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Fludeoxyglucose F-18.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.